PPAR delta: an uncompletely known nuclear receptor (Q24299355)

Peroxisome proliferator activated receptor delta

Europe PubMed Central

title

PPAR delta: an uncompletely known nuclear receptor (English)

0 references

main subject

1 reference

fatty acid beta-oxidation

GOA release 2020-03-11

1 reference

Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors

GOA release 2020-03-11

author name string

A Fredenrich

series ordinal

1

0 references

P A Grimaldi

series ordinal

2

0 references

language of work or name

English

0 references

publication date

February 2005

0 references

published in

Diabetes and Metabolism

0 references

volume

31

0 references

issue

1

0 references

page(s)

23-7

0 references

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Peroxisome proliferator-activated receptors: nuclear control of metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Roles of peroxisome proliferator-activated receptor delta in skeletal muscle function and adaptation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Differential expression of peroxisome proliferator-activated receptors (PPARs): tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Cloning of a protein that mediates transcriptional effects of fatty acids in preadipocytes. Homology to peroxisome proliferator-activated receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Activation of gene transcription by prostacyclin analogues is mediated by the peroxisome-proliferators-activated receptor (PPAR).

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Activation of peroxisome proliferator-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent Obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Transcriptional co-activator PGC-1 alpha drives the formation of slow-twitch muscle fibres

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Effects of PPARalpha, gamma and delta haplotypes on plasma levels of lipids, severity and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

PPARdelta is a very low-density lipoprotein sensor in macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Transcriptional repression of atherogenic inflammation: modulation by PPARdelta

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Pleiotropic actions of peroxisome proliferator-activated receptors in lipid metabolism and atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Mechanism of action of fibrates on lipid and lipoprotein metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

CLA-1/SR-BI Is Expressed in Atherosclerotic Lesion Macrophages and Regulated by Activators of Peroxisome Proliferator-Activated Receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

The roles of PPARs in adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Nonhypoglycemic effects of thiazolidinediones

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Regulation of glyceroneogenesis and phosphoenolpyruvate carboxykinase by fatty acids, retinoic acids and thiazolidinediones: potential relevance to type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021

Peroxisome proliferator-activated receptor γ in diabetes and metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970162-3

7 January 2021